Senior counsel for decisions that can't afford to be slow — or wrong.
We partner with executive teams, Medical Affairs and R&D leaders, and emerging companies to design evidence strategies, adopt AI responsibly and build organizations that decide with speed and conviction.
Advisory focus areas
Evidence generation strategy
Integrated evidence plans that begin in early development, connect clinical and real-world evidence, and are built backward from the decisions payers, regulators and physicians must make.
Medical Affairs transformation
Operating-model design, capability building and launch readiness for Medical Affairs teams moving from support function to strategic driver.
AI adoption & judgment governance
Practical guardrails for AI in consequential decisions — implementing the Judgment Airlock™, exposure tiers and accountability models across functions.
Decision velocity diagnostic
A structured assessment of where decisions stall — governance, data, incentives or behavior — with a prioritized roadmap to remove the drag.
Portfolio & competitive strategy
Independent perspective on portfolio priorities, competitive intelligence and indication strategy across immunology, vaccines, cardiometabolic and beyond.
Startup & board advisory
Hands-on guidance for early-stage biotech and health-tech founders on evidence strategy, clinical positioning and the path to partnership.
Flexible models, senior attention.
Diagnostic sprint
A focused assessment with clear findings and a prioritized action plan.
Strategic advisor
A trusted sounding board for leadership on a retained, monthly basis.
Fractional leadership
Senior Medical Affairs or evidence leadership while you build or transition a team.
Advisory boards
Expert input for scientific, strategic and investor advisory boards.
Built for leaders carrying consequential decisions.
- Pharma and biotech executive teams, Medical Affairs and R&D leadership
- Emerging biotech and health-tech companies preparing for pivotal evidence and partnerships
- Investors seeking independent clinical and evidence-strategy perspective
- Healthcare and cross-industry organizations governing AI in high-stakes decisions
What you can expect
- Direct access to senior, physician-executive expertise — no hand-offs
- Independent perspective, free of vendor or platform bias
- Frameworks proven inside global pharma, adapted to your context
- Clear, decision-ready outputs — not shelfware
Let's accelerate your next critical decision.
Advisory engagements, keynotes and executive workshops for leaders in pharma, biotech, healthcare and beyond.